Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 11, 2011, Pages 1011-1017

  López Suárez, Alejandro ^a   Guerrero, José María Rodríguez ^a   Elvira González, Javier ^a   Beltrán Robles, Manuel ^a   Cañas Hormigo, Francisco ^a   Bascuñana Quirell, Antonio ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

hepatic steatosis; high normal blood pressure; hypertension; nonalcoholic fatty liver disease; steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORRELATIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; ALANINE TRANSAMINASE; BLOOD PRESSURE; BODY MASS INDEX; EPIDEMIOLOGIC METHODS; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; WAIST CIRCUMFERENCE;

EID: 80053621872     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834b8d52     Document Type: Article

References (33)

1. De Alwis NM, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol 2008; 48:S104-S112.
2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrosis. Hepatology 2006; 43:S99-S112.
3. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363:1341-1350.
4. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.
5. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118:1117-1123. (Pubitemid 30346988)
6. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010; 105:2093-2102.
7. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121:91-100. (Pubitemid 32591518)
8. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30:1212-1218. (Pubitemid 46684650)
9. Lin YC, Lo HM, Chen JD. Sonografic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005; 11:4838-4842.
10. Targer G, Bertolini L, Chonchon M, Rodella S, Zoppini G, Lippi G, et al. Nonalcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010; 53:1341-1348.
11. Tarager G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/lasertreated retinopathy in type 2 diabetic patients. Diabetologia 2008; 51:444-450.
12. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sauri H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13:1579-1584. (Pubitemid 46672668)
13. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data. Hapatology 2010; 52:1156-1161.
14. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30:2940-2944. (Pubitemid 350083148)
15. Adams LA, Waters OR, Knuiman MW, Eliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study. Am J Gastroenterol 2009; 104:861-867.
16. Clark JM. The epidemiology on nonalcoholic fatty liver disease. Liver disease in adults. J Clin Gastroenterol 2006; 40:S5-S10. (Pubitemid 44309537)
17. Lau K, Lorbeer R, Haring R, Schmidt CO, Wallaschofski H, Nauck M, et al. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. J Hypertens 2010; 28:1829-1835.
18. López-Suárez A, Elvira-González J, Beltrán-Robles M, Alwakil M, Saucedo JM, Bascuñana-Quirell A, et al. Prevalence of obesity, diabetes, hypertension, hypercholesterolemia and metabolic syndrome in over 50-year-old in Sanlú car de Barrameda, Spain. Rev Esp Cardiol 2008; 61:1150-1158.
19. American Gastroenterologial Association and American Association for the Study of Liver Diseases. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123:1705-1725.
20. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 2010; 51:1979-1987.
21. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007; 13:6419-6424.
22. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143:722-728.
23. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164:2169-2175.
24. Caballería LL, Pera G, Auladell MA, Torán P, Muñoz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol 2010; 22:24-32.
25. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, et al. Increased prevalence of fatty liver in arterial hypertencive patients with normal liver enzymes: Role of insulin resistance. Gut 2004; 53:1020-1023. (Pubitemid 38824162)
26. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011; 140:124-131.
27. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology 2008; 48:792-798.
28. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917-923. (Pubitemid 36397405)
29. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37:1286-1292. (Pubitemid 36667307)
30. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
31. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the Management of arterial hipertensió n: The Task Force for the Management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
32. Vanii E, Bugianesi E, Kotronen A, De Minicis S, Yki-Jä rvinen H, Svegliati- Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 2010; 42:320-330.
33. Brookes MJ, Cooper BT. Hypertension and fatty liver: Guilty by association? J Hum Hypertens 2007; 21:264-270. (Pubitemid 46443587)